Phytopharmacological Update on Cannabis sativa (Ganja): A Mini Review

Tushar      Varshney; Mohit      Sanduja; Devender      Pathak; Anuj   Kumar   Sharma; Vibha      Kumari; Manjul   Pratap   Singh; Mayank      Kulshreshtha
doi:10.2174/0126668629285842240303141227
Abstract

Cannabis sativa L., a significant herbaceous species in Central Asia, has long been valued for its use in traditional medicine and as a source of textile fiber. This fast-growing plant has recently drawn increased attention because of its many applications. It is an abundant source of wood and cellulosic fibers and a true treasure of phytochemicals. This plant greatly interests the construction and pharmaceutical sectors because its metabolites have potent biological effects on human health. Its inner and outer stem tissues may be used to make concrete-like materials and bioplastics. This study aims to summarize the molecular and scientific knowledge of Cannabis sativa, including its pharmacognostic properties, pharmacological potential, phytochemical properties, and prospective future research fields.
Keywords: Cannabis sativa, pharmaceuticals, phytochemical, pharmacognostic, goldmine, bioplastics.
[1]
Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med  2013; 10(5): 210-29.

[2]
Evans WC. Trease and Evans’ Pharmacognosy.  (16th ed.), London: WB Saunders Company Ltd 2008.

[3]
Sofowora A. Medicinal plants and traditional medicine in Africa.  (3rd ed.), Ibadan: Spectrum Books 2008.

[4]
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front Plant Sci  2016; 7: 19.
 [http://dx.doi.org/10.3389/fpls.2016.00019] [PMID:  26870049]

[5]
ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. Prog Chem Org Nat Prod  2017; 103: 1-36.
 [http://dx.doi.org/10.1007/978-3-319-45541-9_1] [PMID:  28120229]

[6]
Baldino L, Scognamiglio M, Reverchon E. Supercritical fluid technologies applied to the extraction of compounds of industrial interest from Cannabis sativa L. and to their pharmaceutical formulations: A review. J Supercrit Fluids  2020; 165: 104960.
 [http://dx.doi.org/10.1016/j.supflu.2020.104960]

[7]
Brunetti P, Pichini S, Pacifici R, Busardò FP, del Rio A. Herbal preparations of medical cannabis: A vademecum for prescribing doctors. Medicina  2020; 56(5): 237.
 [http://dx.doi.org/10.3390/medicina56050237] [PMID:  32429074]

[8]
Lewis MM, Yang Y, Wasilewski E, Clarke HA, Kotra LP. Chemical profiling of medical Cannabis extracts. ACS Omega  2017; 2(9): 6091-103.
 [http://dx.doi.org/10.1021/acsomega.7b00996] [PMID:  30023762]

[9]
Odieka AE, Obuzor GU, Oyedeji OO, Gondwe M, Hosu YS, Oyedeji AO. The medicinal natural products of Cannabis sativa Linn.: A review. Molecules  2022; 27(5): 1689.
 [http://dx.doi.org/10.3390/molecules27051689] [PMID:  35268790]

[10]
WHO World Health Organization. 2016. Available from: https://www.who.int/publications/i/item/9789241510240

[11]
UNODC. 2016. Available from: https://www.unodc.org/e4j/en/crime-prevention-criminal-justice/module-12/index.html

[12]
Modaresi F, Talachian K. The characteristics of clinical trials on cannabis and cannabinoids: a review of trials for therapeutic or drug development purposes. Pharmaceut Med  2022; 36(6): 387-400.
 [http://dx.doi.org/10.1007/s40290-022-00447-7] [PMID:  36357543]

[13]
 Available from: https://sites.google.com/site/indiannamesofplants/via-species/c/cannabis-sativa (Assessed 23-02-2023).

[14]
 Marijuana Available from: http://www.flowersofindia.net/catalog/slides/Marijuana.html (Assessed 23-02-2023).

[15]
 Available from: https://www.google.com/search?q=cannabis+sativa+agriculture&rlz=1C1ONGR

[16]
 Available from: https://www.google.com/search?q=Traditional+use+of+cannabis+sativa+&rlz=1C1ONGR_enIN1021IN1021

[17]
 Available from: https://gobotany.nativeplanttrust.org/species/cannabis/sativa/ (Assessed 27-02-2023).

[18]
Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers  2007; 4(8): 1614-48.
 [http://dx.doi.org/10.1002/cbdv.200790144] [PMID:  17712811]

[19]
Rajavashisth TB, Shaheen M, Norris KC, et al. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open  2012; 2(1): e000494.
 [http://dx.doi.org/10.1136/bmjopen-2011-000494] [PMID:  22368296]

[20]
Cao R, Wang J, Zhang W, et al. Is Marijuana beneficial for prevention and treatment of diabetes? Am J Biomed Sci  2017; 9: 200-10.
 [http://dx.doi.org/10.5099/aj170400200]

[21]
Levendal RA, Frost CL. In vivo effects of Cannabis sativa L. extract on blood coagulation, fat and glucose metabolism in normal and streptozocin-induced diabetic rats. Afr J Tradit Complement Altern Med  2006; 3(4): 1-12.
 [http://dx.doi.org/10.4314/ajtcam.v3i4.31172]

[22]
Ramer R, Hinz B. New insights into antimetastatic and antiangiogenic effects of cannabinoids. Int Rev Cell Mol Biol  2015; 314: 43-116.
 [http://dx.doi.org/10.1016/bs.ircmb.2014.10.005] [PMID:  25619715]

[23]
MacHado Rocha FC, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LMQ, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: Systematic review and meta-analysis. Eur J Cancer Care  2008; 17(5): 431-43.
 [http://dx.doi.org/10.1111/j.1365-2354.2008.00917.x] [PMID:  18625004]

[24]
Alexander A, Smith PF, Rosengren RJ. Cannabinoids in the treatment of cancer. Cancer Lett  2009; 285(1): 6-12.
 [http://dx.doi.org/10.1016/j.canlet.2009.04.005] [PMID:  19442435]

[25]
Freimuth N, Ramer R, Hinz B. Antitumorigenic effects of cannabinoids beyond apoptosis. J Pharmacol Exp Ther  2010; 332(2): 336-44.
 [http://dx.doi.org/10.1124/jpet.109.157735] [PMID:  19889794]

[26]
Sevcík J, Masek K. Potential role of cannabinoids in Parkinson’s disease. Drugs Aging  2000; 16(6): 391-5.
 [http://dx.doi.org/10.2165/00002512-200016060-00001] [PMID:  10939305]

[27]
Hernandez F, Chandra S. The current state and potential direction of cannabis research. J Complement Integr Med  2016; 6: 44-8.

[28]
Sharma SR, Gupta P, Kumar R, Singh B. Marijuana from poison to pills A Review JIAFM  2006; 28: 162-9.

[29]
Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol  2004; 88(5): 708-13.
 [http://dx.doi.org/10.1136/bjo.2003.032250] [PMID:  15090428]

[30]
Swift W, Gates P, Dillon P. Survey of Australians using cannabis for medical purposes. Harm Reduct J  2005; 2(1): 18.
 [http://dx.doi.org/10.1186/1477-7517-2-18] [PMID:  16202145]

[31]
Selvarajah D, Gandhi R, Emery CJ, Tesfaye S. Randomized placebo-controlled doubleblind clinical trial of cannabis based medicinal product (Sativex) in painful diabetic neuropathy. Diabetes Care  2010; 33(1): 128-30.
 [http://dx.doi.org/10.2337/dc09-1029] [PMID:  19808912]

[32]
Denson TF, Earleywine M. Decreased depression in marijuana users. Addict Behav  2006; 31(4): 738-42.
 [http://dx.doi.org/10.1016/j.addbeh.2005.05.052] [PMID:  15964704]

[33]
Fukuda S, Kohsaka H, Takayasu A, et al. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. BMC Musculoskelet Disord  2014; 15(1): 275.
 [http://dx.doi.org/10.1186/1471-2474-15-275] [PMID:  25115332]

[34]
Bridgeman MB, Daniel T, Abazia DT. Medicinal cannabis: History, pharmacology, and implications for the acute care setting. P&T  2017; 42(3): 180-8.

[35]
Moisto SA, Galizio M, Connors GJ. Drug Use and Abuse.  (3rd ed.), New York: Harcourt Brace College Publishers 1999.

[36]
Meiri E, Jhangiani H, Vredenburgh JJ, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin  2007; 23(3): 533-43.
 [http://dx.doi.org/10.1185/030079907X167525] [PMID:  17355735]

[37]
Alsasua del Valle A. Implication of cannabinoids in neurological diseases. Cell Mol Neurobiol  2006; 26(4-6): 577-89.
 [http://dx.doi.org/10.1007/s10571-006-9070-8] [PMID:  16699878]

[38]
Ayenigbara GO. Cannabis sativa: A plant with multiple utilities, misunderstood, and a victim of controversial hypocrisy. J Emerg Trends Educ Res Policy Stud  2014; 5: 54-9.

[39]
Tashkin DP. Does marijuana pose risks for chronic airflow obstruction? Ann Am Thorac Soc  2015; 12(2): 235-6.
 [http://dx.doi.org/10.1513/AnnalsATS.201412-581ED] [PMID:  25706487]

[40]
Fischer B, Imtiaz S, Rudzinski K, Rehm J. Crude estimates of cannabis-attributable mortality and morbidity in Canada–implications for public health focused intervention priorities. J Public Health  2016; 38(1): 183-8.
 [http://dx.doi.org/10.1093/pubmed/fdv005] [PMID:  25630540]

[41]
Lai HMX, Sitharthan T. Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. Am J Drug Alcohol Abuse  2012; 38(6): 567-74.
 [http://dx.doi.org/10.3109/00952990.2012.694523] [PMID:  22746224]

[42]
Sanches RF, Marques JMA. Cannabis e humor. Rev Bras Psiquiatr  2010; 32(2): 173-80.
 [http://dx.doi.org/10.1590/S1516-44462010000200014] [PMID:  20658056]

[43]
Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord  2016; 195: 63-74.
 [http://dx.doi.org/10.1016/j.jad.2016.02.007] [PMID:  26872332]

[44]
du Plessis SS, Agarwal A, Syriac A. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. J Assist Reprod Genet  2015; 32(11): 1575-88.
 [http://dx.doi.org/10.1007/s10815-015-0553-8] [PMID:  26277482]

[45]
The classification of cannabis under the misuse of drugs act 1971, advisory council on the misuse of drugs. 2002. Available from: https://assets.publishing.service.gov.uk/media/5a7ac2d840f0b66a2fc029f0/cannabis-class-misuse-drugs-act.pdf

[46]
Hazekamp A, Simons R, Peltenburg-Looman A, Sengers M, van Zweden R, Verpoorte R. Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography. J Liq Chromatogr Relat Technol  2004; 27(15): 2421-39.
 [http://dx.doi.org/10.1081/JLC-200028170]

[47]
Leghissa A, Hildenbrand ZL, Schug KA. A review of methods for the chemical characterization of cannabis natural products. J Sep Sci  2018; 41(1): 398-415.
 [http://dx.doi.org/10.1002/jssc.201701003] [PMID:  28986974]

[48]
Citti C, Braghiroli D, Vandelli MA, Cannazza G. Pharmaceutical and biomedical analysis of cannabinoids: A critical review. J Pharm Biomed Anal  2018; 147: 565-79.
 [http://dx.doi.org/10.1016/j.jpba.2017.06.003] [PMID:  28641906]

[49]
De Backer B, Debrus B, Lebrun P, et al. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. J Chromatogr B Analyt Technol Biomed Life Sci  2009; 877(32): 4115-24.
 [http://dx.doi.org/10.1016/j.jchromb.2009.11.004] [PMID:  19932642]

[50]
Aizpurua-Olaizola O, Soydaner U, Öztürk E, et al. Evolution of the cannabinoid and Terpene content during the growth of Cannabis sativa plants from different Chemotypes. J Nat Prod  2016; 79(2): 324-31.
 [http://dx.doi.org/10.1021/acs.jnatprod.5b00949] [PMID:  26836472]

[51]
Dallüge J, Beens J, Brinkman UAT. Comprehensive two-dimensional gas chromatography: A powerful and versatile analytical tool. J Chromatogr A  2003; 1000(1-2): 69-108.
 [http://dx.doi.org/10.1016/S0021-9673(03)00242-5] [PMID:  12877167]

[52]
Gröger T, Schäffer M, Pütz M, et al. Application of two-dimensional gas chromatography combined with pixel-based chemometric processing for the chemical profiling of illicit drug samples. J Chromatogr A  2008; 1200(1): 8-16.
 [http://dx.doi.org/10.1016/j.chroma.2008.05.028] [PMID:  18539290]

[53]
Omar J, Olivares M, Amigo JM, Etxebarria N. Resolution of co-eluting compounds of Cannabis sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with multivariate curve resolution-alternating least squares. Talanta  2014; 121: 273-80.
 [http://dx.doi.org/10.1016/j.talanta.2013.12.044] [PMID:  24607138]

[54]
Beasley E, Francese S, Bassindale T. Detection and mapping of cannabinoids in single hair samples through rapid derivatization and matrix-assisted laser desorption ionization mass spectrometry. Anal Chem  2016; 88(20): 10328-34.
 [http://dx.doi.org/10.1021/acs.analchem.6b03551] [PMID:  27648476]

[55]
Hazekamp A, Peltenburg A, Verpoorte R, Giroud C. Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa. J Liq Chromatogr Relat Technol  2005; 28(15): 2361-82.
 [http://dx.doi.org/10.1080/10826070500187558]

[56]
Mutje P. Full exploitation of Cannabis sativa as reinforcement/filler of thermoplastic composite materials. Compos A Appl Sci Manuf  2007; 38(2): 369-77.

[57]
Pourseyed Lazarjani M, Torres S, Hooker T, Fowlie C, Young O, Seyfoddin A. Methods for quantification of cannabinoids: A narrative review. Journal of Cannabis Research  2020; 2(1): 35.
 [http://dx.doi.org/10.1186/s42238-020-00040-2] [PMID:  33526084]

[58]
Zuardi AW. History of cannabis as a medicine: A review. Rev Bras Psiquiatr  2006; 28(2): 153-7.
 [http://dx.doi.org/10.1590/S1516-44462006000200015] [PMID:  16810401]

[59]
Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature  1993; 365(6441): 61-5.
 [http://dx.doi.org/10.1038/365061a0] [PMID:  7689702]

[60]
Devane WA, Hanuš L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science  1992; 258(5090): 1946-9.
 [http://dx.doi.org/10.1126/science.1470919] [PMID:  1470919]

[61]
Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature  1997; 388(6644): 773-8.
 [http://dx.doi.org/10.1038/42015] [PMID:  9285589]

[62]
Sugiura T, Kishimoto S, Oka S, Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res  2006; 45(5): 405-46.
 [http://dx.doi.org/10.1016/j.plipres.2006.03.003] [PMID:  16678907]

[63]
Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci  2003; 4(11): 873-84.
 [http://dx.doi.org/10.1038/nrn1247] [PMID:  14595399]

[64]
De Petrocellis L, Di Marzo V. An introduction to the endocannabinoid system: From the early to the latest concepts. Best Pract Res Clin Endocrinol Metab  2009; 23(1): 1-15.
 [http://dx.doi.org/10.1016/j.beem.2008.10.013] [PMID:  19285257]

[65]
Abouchedid R, Ho JH, Hudson S, et al. Acute toxicity associated with use of 5F-derivations of synthetic cannabinoid receptor agonists with analytical confirmation. J Med Toxicol  2016; 12(4): 396-401.
 [http://dx.doi.org/10.1007/s13181-016-0571-7] [PMID:  27456262]

[66]
Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol  1992; 16(5): 276-82.
 [http://dx.doi.org/10.1093/jat/16.5.276] [PMID:  1338215]

[67]
Lemberger L, Axelrod J, Kopin IJ. Metabolism and disposition of delta-9-tetrahydrocannabinol in man. Pharmacol Rev  1971; 23(4): 371-80.
 [PMID:  4943951]

[68]
Goullé JP, Saussereau E, Lacroix C. (Delta-9-tetrahydrocannabinol pharmacokinetics). Ann Pharm Fr  2008; 66(4): 232-44.
 [http://dx.doi.org/10.1016/j.pharma.2008.07.006] [PMID:  18847571]

[69]
Vandevenne M, Vandenbussche H, Verstraete A. Detection time of drugs of abuse in urine. Acta Clin Belg  2000; 55(6): 323-33.
 [http://dx.doi.org/10.1080/17843286.2000.11754319] [PMID:  11484423]

[70]
Huestis MA. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Handb Exp Pharmacol  2005; 168(168): 657-90.
 [http://dx.doi.org/10.1007/3-540-26573-2_23] [PMID:  16596792]

[71]
Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet  2003; 42(4): 327-60.
 [http://dx.doi.org/10.2165/00003088-200342040-00003] [PMID:  12648025]

[72]
Lindgren JE, Ohlsson A, Agurell S. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology  1981; 74(3): 208-12.

[73]
Wall M, Perez-Reyes M. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol  1981; 21(S1): 178S-89S.
 [http://dx.doi.org/10.1002/j.1552-4604.1981.tb02594.x] [PMID:  6271823]

[74]
Smith-Kielland A, Skuterud B, Mørland J. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol  1999; 23(5): 323-32.
 [http://dx.doi.org/10.1093/jat/23.5.323] [PMID:  10488918]

[75]
Harvey DJ. Metabolism and pharmacokinetics of the cannabinoids. In: Watson RR, Ed. Biochemistry and physiology of substance abuse.  Boca Raton, FL: CRC Press 1991; pp. 279-365.

[76]
Hawksworth G, McArdle K. Metabolism and pharmacokinetics of cannabinoids. In: Guy GW, Whittle BA, Robson PJ, Eds. The medicinal uses of cannabis and cannabinoids.  London: Pharmaceutical Press 2004; pp. 205-28.

[77]
Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers  2007; 4(8): 1770-804.
 [http://dx.doi.org/10.1002/cbdv.200790152] [PMID:  17712819]

[78]
Huestis MA, Smith ML. Cannabinoid pharmacokinetics and disposition in alternative matrices. In: Pertwee RG, Ed. Handbook of cannabis.  Oxford: Oxford University Press 2014; pp. 296-316.
 [http://dx.doi.org/10.1093/acprof:oso/9780199662685.003.0016]

[79]
Devinsky O, Cilio MR, Cross H, et al. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia  2014; 55(6): 791-802.
 [http://dx.doi.org/10.1111/epi.12631] [PMID:  24854329]

[80]
Almogi-Hazan O, Or R. Cannabis, the endocannabinoid system and immunity—the journey from the bedside to the bench and back. Int J Mol Sci  2020; 21(12): 4448.
 [http://dx.doi.org/10.3390/ijms21124448] [PMID:  32585801]

[81]
Salzet M, Breton C, Bisogno T, Di Marzo V. Comparative biology of the endocannabinoid system. Eur J Biochem  2000; 267(16): 4917-27.
 [http://dx.doi.org/10.1046/j.1432-1327.2000.01550.x] [PMID:  10931174]

[82]
Ingvardsen CR, Brinch-Pedersen H. Challenges and potentials of new breeding techniques in Cannabis sativa. Front Plant Sci  2023; 14: 1154332.
 [http://dx.doi.org/10.3389/fpls.2023.1154332] [PMID:  37360738]
Rights & Permissions Print Cite
Article Metrics
5
2
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/0126668629285842240303141227	Print ISSN 2666-8629
Publisher Name Bentham Science Publisher	Online ISSN 2666-8637
Current Functional Foods

Phytopharmacological Update on Cannabis sativa (Ganja): A Mini Review

Abstract

Related Journals

Related Books
